Reaction
Cytogenetic Analysis Abnormal reporting signals
As of the last recalculation, Cytogenetic Analysis Abnormal appears in 1,040 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is NILOTINIB (PRR 640.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nilotinib | 495 | 640.1 | 651.1 |
| Imatinib | 271 | 415.5 | 422.0 |
| Bosutinib | 110 | 273.9 | 277.3 |
| Dasatinib | 213 | 144.0 | 144.8 |
| Imatinib Mesylate | 91 | 71.5 | 71.7 |
| Hydroxyurea | 52 | 51.8 | 51.9 |
| Pegaspargase | 8 | 13.2 | 13.2 |
| Azacitidine For | 7 | 7.7 | 7.8 |
| Eltrombopag Olamine | 7 | 6.1 | 6.1 |